| 2.78 0.11 (4.12%) | 01-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.27  |
1-year : | 3.81 |
| Resists | First : | 2.79 |
Second : | 3.27 |
| Pivot price | 1.94 |
|||
| Supports | First : | 2.03 |
Second : | 1.57 |
| MAs | MA(5) : | 2.41 |
MA(20) : | 1.9 |
| MA(100) : | 1.91 |
MA(250) : | 1.23 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 94.8 |
D(3) : | 91.8 |
| RSI | RSI(14): 79 |
|||
| 52-week | High : | 3.24 | Low : | 0.27 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HYFT ] has closed above the upper band by 6.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 107.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.8 - 2.81 | 2.81 - 2.82 |
| Low: | 2.49 - 2.5 | 2.5 - 2.51 |
| Close: | 2.76 - 2.78 | 2.78 - 2.79 |
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Thu, 08 Jan 2026
MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - simplywall.st
Mon, 15 Dec 2025
MindWalk Holdings Emphasizes AI-Driven Strategy in Latest Financial Release - TipRanks
Mon, 15 Dec 2025
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Benzinga
Mon, 15 Dec 2025
MindWalk Holdings (HYFT) Reports Strong Revenue Growth Despite E - GuruFocus
Mon, 15 Dec 2025
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Mon, 15 Dec 2025
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView — Track All Markets
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 47 (M) |
| Shares Float | 42 (M) |
| Held by Insiders | 8.9 (%) |
| Held by Institutions | 8.8 (%) |
| Shares Short | 473 (K) |
| Shares Short P.Month | 592 (K) |
| EPS | -0.58 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | -112 % |
| Operating Margin | -67.3 % |
| Return on Assets (ttm) | -15.1 % |
| Return on Equity (ttm) | -118.3 % |
| Qtrly Rev. Growth | 53.9 % |
| Gross Profit (p.s.) | 0.32 |
| Sales Per Share | 0.57 |
| EBITDA (p.s.) | -0.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -4.8 |
| PEG Ratio | 0 |
| Price to Book value | 9.92 |
| Price to Sales | 4.87 |
| Price to Cash Flow | -13.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|